Provera price in mercury drug philippines

What is Depo-Provera?

Depo-Provera tablets are used to treat the painful conditions caused by menopause, such as vaginal dryness, itching, and burning. It is also used to reduce the risk of getting infections due to the sexually transmitted infections (STIs) like chlamydia and gonorrhea. Besides this, Depo-Provera also helps to relieve the symptoms of under- or overactive or adrenal gland (e.g., fatigue, weight gain, excessive thirst, urination, etc.).

How does Depo-Provera work?

Depo-Provera belongs to the hormone replacement drug class and works by replacing the hormone your body naturally produces. Depo-Provera stops the ovaries from releasing an egg each month, which can cause the menstrual cycle to restart and thus reduce the risk of getting infections like chlamydia, syphilis, and gonorrhea. It also helps to reduce the likelihood of getting infections due to the sexually transmitted infections (STIs) like chlamydia and gonorrhea.

Side Effects of Depo-Provera

As with any medication, there is a possibility of side effects, although these are rare.

The most common side effects of Depo-Provera are nausea, headache, abdominal pain, and breast tenderness. These side effects usually resolve on their own within a few days or a week of discontinuing the medication.

Other side effects that usually occur are itching or burning in the breasts, changes in menstrual periods, or changes in your mood or behaviour.

If you experience any of the following side effects while taking Depo-Provera contact your doctor or pharmacist for further advice.

-Feeling sick (nausea), vomiting, stomach pain or diarrhea-Feeling depressed or worried-Blurred vision or loss of vision-High blood pressure-Stunted or have ever had a stroke-High cholesterol-High levels of a substance in your blood called “lipase”-High or “serotonin”-High or “histosterone”-Low levels of “calcium” in your blood-Low levels of “Hippocratic” (the length of your menstrual cycle)-Reduced bone mineral density-Bone dryness or dryness of vagina (menstrual bone)

Depo-Provera can also cause birth defects in unborn babies. If you are at risk of a major birth defect, your doctor may want to increase the number of women with a history of a history of birth defects. Also, your doctor may want to stop Depo-Provera use for a period of time, at a dosage that is safe for you to take.

If you experience any side effects that bother you or do not go away, contact your doctor or visit your menstrual doctor.

Note: This medication only works if you are sexually stimulated.

Read More This Medication Is A Prescription Rebox.

How long does it take for Depo-Provera to work?

The length of time it takes for Depo-Provera to work may vary depending on several factors, including the size of the affected area, your age, other medical conditions, and whether you take it with a heavy or a well-balanced diet.

Rationale:Birth control methods and their associated risks can prevent more than 1 million new pregnancies in the United States each year. This information has important implications for policymakers. The potential to be pregnant with a child with an intact uterus and without the need for an implantation has led to increased concern and research.

Despite being a public health emergency, birth control methods have been found to be associated with increased risk of major birth defects, such as a baby born with a blood-borne malformation or a baby with a blood clot in the lungs. While these risks are generally lower than those associated with traditional birth control methods, they are still significant. Birth control methods have been linked to more than a million unintended pregnancies in the United States, and they may cause additional risk for a pregnancy that is not fully grown.

There are several factors that can increase the likelihood of a child being born with a malformation or with a blood clot in the lungs and uterus, particularly if the method is used to prevent pregnancy. The most common side effects of these methods include vomiting, diarrhea, and nausea, particularly in the first few months of use.

What is Depo Provera?

Depo Provera, or DMPA, is an injectable, contraceptive injection that is administered every 3 to 5 days. Depo Provera is administered in a controlled manner, but it is usually given via a daily vaginal ring, or by a single injection, and is often used in combination with other methods of contraception, such as an intrauterine device (IUD) and intrauterine contraceptive (IEC) implant. This method is a pregnancy prevention method that can be used to prevent a single birth within two months of the start of a pregnancy. A pregnancy prevention method can also be used to prevent a pregnancy from occurring without birth control.

As with other hormonal birth control methods, Depo Provera may be used as a contraceptive method for women who are at a higher risk of developing a serious medical condition or are at an increased risk of birth defects. This method is sometimes used when other methods are not available or when the method requires a special monitoring system. It is not covered by most insurance plans or by most medical assistance programs. In addition, Depo Provera is not covered by most insurance plans or by most medical assistance programs.

Side Effects:The side effects associated with the use of Depo Provera for preventing pregnancy are relatively minor. These side effects are generally mild and temporary, but if they occur, they can be serious. They include nausea, vomiting, headache, abdominal pain, weight gain, breast tenderness, and a small or large black or white discharge. These side effects are generally more common in women who are not using hormonal contraceptives, and these side effects are usually reversible.

There are several different types of birth control methods. Depo Provera is the most common method of birth control, and the other methods of birth control are the most common.

The most common side effects of Depo Provera for women who are at a high risk of a serious medical condition or who are at a higher risk of birth defects are nausea, vomiting, diarrhea, headache, and abdominal pain. In addition, these side effects are usually reversible.

Common Side Effects:The common side effects of Depo Provera are nausea, vomiting, headache, abdominal pain, and weight gain. These side effects are generally mild and temporary, and they usually improve as the body adjusts to the new method of birth control. These side effects are usually mild and temporary, but they can be serious and permanent. If these side effects persist or worsen, it is important to speak with a doctor. It is also important to remember that while the side effects of Depo Provera are minor, they are still important because they can be serious and permanent.

Long-Term Side Effects:Long-term side effects of Depo Provera include the development of congenital abnormalities in the brain or spine and the use of birth control pills to prevent pregnancy. In addition, Depo Provera is sometimes used in combination with other methods of contraception, such as intrauterine devices and IECs, to prevent pregnancy. If you or a child is at a high risk of developing a serious medical condition or are at an increased risk of birth defects, it is important to talk with your doctor.

The most common side effects of Depo Provera for women who are at a high risk of a serious medical condition or who are at a higher risk of birth defects are vomiting, diarrhea, nausea, and abdominal pain. In addition, these side effects are usually mild and temporary.

A study published inNew England Journal of Medicineon a combination contraceptive injection in men who have an HLA-B rearrangement at a genetic locus identified in a population-based study as a potential treatment for an endometrial tumor (ET) in women of reproductive age. Patients received a combined injection of medroxyprogesterone acetate (MPA) and ethinylestradiol acetate (EAP). The study involved 1,073 patients with endometrial cancer that was treated with a single daily injection of MPA and EAP combined. The study compared patients who received MPA, EAP and a placebo (an inactive drug). The patients who had a tumor diagnosis and were older (≥ 35 years) were more likely to have a high grade endometrial carcinoma. Patients who were treated with EAP showed a higher percentage of endometrial cancer than patients who received MPA. In addition, the women who had a tumor diagnosis were more likely to have high-grade endometrial carcinoma than women who were treated with EAP. The study concluded that MPA alone can be used as a single treatment option for an HLA-B rearrangement.

EAP has been shown to be effective at controlling the growth of endometrial cancer in women with an HLA-B rearrangement. MPA and EAP have been used in other studies as well, although they are not FDA-approved for use in these studies. MPA is approved for the treatment of endometrial carcinoma in postmenopausal women. EAP is used to treat endometrial tumors that are hormone-responsive or hormone dependent. Both of these medications are available as tablets, capsules or injection. A combination of MPA and EAP is currently being evaluated in phase II studies for use as an adjuvant therapy for early breast cancer. MPA and EAP are currently FDA-approved and should be considered as an adjuvant treatment for early breast cancer in postmenopausal women. A phase II study of MPA and EAP in postmenopausal women with endometrial carcinoma is currently underway.

The American Urological Association (AUA) is a national organization that works to help low-income women achieve their potential by providing information about the benefits and risks of hormone therapy (HRT) for those with an HLA-B rearrangement. The AUA also recommends that women who have an HLA-B rearrangement at a genetic locus be treated with an HRT progestogen, such as oestrogen or progestogen. The U. S. Preventive Services Task Force (USPSTF) also recommends that women who have an HLA-B rearrangement at a genetic locus be treated with an HRT progestogen, such as oestrogen or progestogen. Preventive Services Task Force also recommends that women who have an HLA-B rearrangement at a genetic locus be treated with an HRT progestogen, such as oestrogen or progestogen.

Although the studies have not been conducted in this specific population, there is some evidence that patients who are treated with either hormonal contraception or HRT have an increased risk for endometrial cancer. The overall data from this study did not show an increased risk for endometrial cancer. However, patients who received a combination of hormonal contraception and HRT were at an increased risk for endometrial cancer compared to those who received only hormonal contraception alone. The researchers concluded that, if a woman had an HLA-B rearrangement at a genetic locus, her risk for endometrial cancer would be similar to that of a woman who received only hormonal contraception and HRT. The study authors suggest that the risk for endometrial cancer would be similar to that of a woman who received only hormonal contraception and HRT.

Medroxyprogesterone Acetate (MPA) and EAP

MPA and EAP, also known as medroxyprogesterone acetate, are widely used in the treatment of endometrial cancer and have been shown to be effective in reducing the growth of endometrial tumors. Although the data on this combination contraceptive injection is limited, it has been shown to be effective at controlling the growth of an HLA-B rearrangement. In addition, MPA and EAP are currently FDA-approved in the United States and the United Kingdom.

Preventive Services Task Force recommends that women who have an HLA-B rearrangement at a genetic locus be treated with an HRT progestogen, such as oestrogen or progestogen.

Provera 5mg

Provera 5mg tablet contains the active substance medroxyprogesterone acetate. It is a synthetic progestogen used to prevent or treat certain types of ovulatory disorders (such as irregular periods, endometriosis, and polycystic ovarian syndrome). It works by preventing the body from releasing the egg from the ovary. It also helps to increase the chances of pregnancy.

Benefits

  • Increases chances of ovulation in women who have irregular periods.
  • Treats symptoms of endometriosis, endometrial hyperplasia, and polycystic ovary syndrome.
  • Contains the active ingredient medroxyprogesterone acetate.
  • It is used to prevent or treat menstrual cramps and irregular cycles.
  • Prevents pregnancy if taken for more than 21 days.
  • Contains the active ingredient clomiphene citrate.

Side Effects

While Provera 5mg can provide effective relief, it can also have side effects. These may include:

  • Breast tenderness
  • Headache
  • Nausea
  • Weight gain
  • Mood changes
  • Depression
  • Irregular menstrual periods or irregular menses
  • Bone loss

If you experience any of these symptoms, you should contact your GP, as they may be able to offer further advice.

Precautions

  • Take Provera 5mg tablet by mouth with a full glass of water to avoid stomach upset.
  • Keep Provera 5mg tablets out of reach of children.
  • Do not take it if you are breastfeeding or have any other medical conditions.
  • Consult your doctor before using any medication for any condition.

Safety

Provera 5mg is generally safe to use during pregnancy. However, it should be used under medical supervision and in accordance with the instructions provided with the tablet.

If you experience any side effects, such as mood swings, feelings of sadness, or allergic reactions, consult your doctor immediately.

Provera 5mg Tablet Side Effects

Common side effects of Provera 5mg may include:

  • Dizziness
  • Upset stomach
  • Breast pain
Some common side effects of Provera 5mg may include:
  • Blurred vision
  • Changes in color vision
  • Decreased blood pressure
Consult your doctor before using Provera 5mg Tablet if you experience any severe side effects, such as:
  • Fainting
  • Shortness of breath
  • Muscle pain
  • Trouble speaking
  • Loss of appetite
  • Abnormal bleeding
  • Weight changes
  • Trouble swallowing

If you experience any severe side effects of Provera 5mg, you should contact your doctor immediately.